|
|
Volumn 28, Issue 2, 1997, Pages 108-116
|
|
Acute lymphoblastic leukemia in children: Normalized comparison of conventional vs. intensive chemotherapy at the National Cancer Institute of Colombia
a
|
|
Author keywords
intensive chemotherapy; nonrandomized comparison of therapy; pediatric acute lymphoblastic leukemia
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
DEXAMETHASONE;
DOXORUBICIN;
MERCAPTOPURINE;
METHOTREXATE;
PREDNISONE;
VINCRISTINE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADOLESCENT;
ARTICLE;
BRAIN PROTECTION;
CANCER CHEMOTHERAPY;
CHILD;
CHILDHOOD LEUKEMIA;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
COHORT ANALYSIS;
COLOMBIA;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEVELOPING COUNTRY;
DRUG EFFICACY;
FEMALE;
HUMAN;
HUMAN TISSUE;
INFANT;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRATHECAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKEMIA REMISSION;
LEUKOCYTE COUNT;
MAINTENANCE THERAPY;
MAJOR CLINICAL STUDY;
MALE;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RELAPSE;
SKULL IRRADIATION;
TREATMENT OUTCOME;
6-MERCAPTOPURINE;
ADOLESCENT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ASPARAGINASE;
CHILD;
CHILD, PRESCHOOL;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
DOXORUBICIN;
DRUG ADMINISTRATION SCHEDULE;
FEASIBILITY STUDIES;
FEMALE;
HUMANS;
INFANT;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L1;
MALE;
METHOTREXATE;
PREDNISONE;
RISK FACTORS;
TREATMENT OUTCOME;
VINCRISTINE;
|
|
EID: 0031022271
PISSN: 00981532
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1096-911X(199702)28:2<108::AID-MPO4>3.0.CO;2-O Document Type: Article |
|
Times cited : (8)
|
|
References (58)
|
